Skip to Content

Nexium Sales Data

Rank 2 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Nexium U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 2 0.74% -2.75%
Q3 2013 2 4.89% -10.76%
Q2 2013 2 -0.34% -8.43%
Q1 2013 2 1.21% -2.47%
Q4 2012 2 (1) 1.45% 2.01%
Q3 2012 1 2.93% 4.10%
Q2 2012 1 (1) -1.12% -2.05%
Q1 2012 2 (1) -3.08% -6.18%
Q4 2011 3 -0.10% -1.60%
Q3 2011 3 -5.64% -4.78%
Q2 2011 3 -1.65% -0.77%
Q1 2011 3

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
July 3, 2017Can Your Heartburn Meds Shorten Your Life?
June 28, 2017Popular Heartburn Meds Don't Raise Alzheimer's Risk: Study
March 27, 2017Study Suggests Heartburn Meds-Superbug Infections Link
January 5, 2017Heartburn Drugs May Raise Risk of Stomach Infections: Study
November 15, 2016Could Common Heartburn Drugs Up Stroke Risk?
April 12, 2016Doctors Often Overestimate Promise of Newly Approved Drugs
February 15, 2016Widely Used Heartburn Drugs Linked to Dementia Risk in Study
October 27, 2015Chronic Heartburn Drugs Tied to Higher Risk of Kidney Disease
June 10, 2015Popular Heartburn Meds Linked to Higher Risk of Heart Attack
January 29, 2015Monthly News Roundup - January 2015
December 10, 2013Acid-Reflux Drugs Tied to Lower Levels of Vitamin B-12
Hide